EDAP TMS SA ADR

FOCLNASDAQ · USD
4.21USD+0.06 (+1.45%)
239

EDAP TMS SA ADR (FOCL) Option Chain

As of September 18, 2026, EDAP TMS SA ADR is trading at $4.21, a +1.45% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 134.6%. IV Rank is —%.

Read more

Tracking the FOCL option chain helps you see every strike and expiry on EDAP TMS SA ADR in one view, so you can quickly identify the contracts that fit your thesis and your risk. EDAP TMS SA ADR's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of FOCL options activity at a glance. Use our scanner to monitor the FOCL option chain in real time and filter for the FOCL options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For FOCL stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the FOCL option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where FOCL stock options are being actively traded and where they are not.

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications.

This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls EDAP TMS SA ADR's full chain across every expiry, highlights the most liquid strikes, and lets you screen FOCL options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of FOCL stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryMedical Distribution
  • SectorHealthcare
  • IV percentile
  • Market cap (M$)156
  • 52 weeks high-35.16%
  • 52 weeks low137.14%
  • Analyst recommendationBuy
    1.80
  • Target price$8.80
    109.03% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-1.04
  • EPS growth next 5 years12.03%

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
11.4400-0.061.711.152.152.50-39.760.750.000.750088.56
75.264500.950.000.955.00+20.480.453.100.790.980024.74
96.29001.250.001.257.50+80.722.503.903.29-0.09003.71

As of September 18, 2026

Scan the full option chain in one place

Browse the full FOCL option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial